CA

Calliditas Therapeutics ABSTO Calliditas Therapeutics Stock Report

Last reporting period 30 Jun, 2024

Updated 10 Oct, 2024

Last price

Market cap $B

1.095

Small

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

Cash flow from operating activities CFO

-0.007 B

Last period CFO ,SEK

88%

CFO has increased in 5 years


What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO of Calliditas Therapeutics ?

Calliditas Therapeutics`s CFO for the period ended 2024-06-30 is -0.007 B SEK

View Full Company Analysis